Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124870292 | 12487029 | 2 | F | 20160609 | 20160706 | 20160622 | 20160712 | EXP | JP-ROCHE-1780238 | ROCHE | 63.00 | YR | M | Y | 0.00000 | 20160712 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124870292 | 12487029 | 1 | PS | XELODA | CAPECITABINE | 1 | Oral | DOSAGE IS UNCERTAIN. | U | 20896 | 1800 | MG | TABLET | BID | |||||
124870292 | 12487029 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | THE FRACTIONATION DOSE FREQUENCY IS UNCERTAIN. ?DOSE INTERVAL UNCERTAINTY | U | 0 | 130 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124870292 | 12487029 | 1 | Gastric cancer |
124870292 | 12487029 | 2 | Gastric cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124870292 | 12487029 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124870292 | 12487029 | Enterocolitis | |
124870292 | 12487029 | Neutrophil count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124870292 | 12487029 | 1 | 20160530 | 20160608 | 0 |